Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention

Figure 6

Treatment effects on serum n-3FA (a), n-6FA (b), and their ratio n3FA/n-6FA (c). The number of subjects was 8 in the control, 11 in the Lovaza 4 g group, and 8 in the Lovaza 4 g + Ral 30 mg group. Data represent mean values ± s.e.m. versus the other groups. Reproduced with permission from [36].

(a)

(b)

(c)